Dr Agarwal's Health Care Reports Stellar Q3 FY26 Performance with 54.5% PAT Surge
Chennai-based eye care chain Dr Agarwal's Health Care has announced impressive financial results for the third quarter of the fiscal year 2025-26, showcasing substantial growth across key metrics. The company reported a remarkable 54.5% increase in Profit after Tax (PAT), which soared to Rs 44 crore for the quarter ended December 31, 2025, compared to Rs 28 crore in the same period last year.
Revenue Growth and Operational Highlights
In addition to the profit surge, the healthcare provider's revenue from operations grew by 23% year-on-year, reaching Rs 530 crore in Q3 FY26, up from Rs 431 crore in the corresponding quarter of the previous fiscal year. This robust financial performance is underpinned by significant expansion in the company's network.
As of December 31, 2025, Dr Agarwal's Health Care's network comprised 272 facilities, with the addition of 38 new centers during the first half of the fiscal year. This strategic growth has been instrumental in driving the company's success, as highlighted by CEO Adil Agarwal.
CEO Insights and Future Strategy
Adil Agarwal, CEO of Dr Agarwal's Health Care, attributed the strong performance to several key factors. "We delivered a strong performance driven by healthy patient volumes, strong traction across mature centres, and improving contribution from newer facilities," he stated in a company release issued from Chennai.
Looking ahead, Agarwal emphasized the company's commitment to sustained growth. "We remain focused on accelerating organic growth through aggressive greenfield expansion, deepening our presence in existing markets while selectively entering newer geographies," he added. This strategic approach aims to leverage the company's established brand and operational expertise to capture emerging opportunities in the eye care sector.
Industry Context and Implications
The impressive results from Dr Agarwal's Health Care reflect broader trends in India's healthcare industry, where specialized chains are experiencing increased demand. The company's focus on both mature and new facilities has enabled it to balance stability with innovation, contributing to its financial resilience.
Key drivers behind this performance include:
- Enhanced patient volumes across all centers, indicating strong brand trust and service quality.
- Operational efficiency in mature locations, which continue to deliver consistent results.
- Strategic network expansion, with new centers gradually increasing their contribution to overall revenue.
As Dr Agarwal's Health Care continues to expand its footprint, these results position it as a leading player in India's competitive eye care market, with potential for further growth in the coming quarters.
